abs329.txt	continuous	exposure	of	a	pancreatic	cancer	cell	line	mia	paca-2	(mias)	togemcitabine	resulted	in	the	formation	of	a	gemcitabine-resistant	subline	(miar)	in	an	effort	to	discover	kinase	inhibitors	that	inhibited	miar	growth		miar	cellswere	exposed	to	kinase	inhibitors	(pkis-1	library)	in	a	384-well	screeningformat		three	compounds	(unc10112721a		unc10112652a		and	unc10112793a)	wereidentified	that	inhibited	the	growth	of	miar	cells	by	more	than	50%	(at	50	nm)	two	compounds	(unc10112721a	and	unc10112652a)	were	classified	as	cyclin-dependentkinase	(cdk)	inhibitors		whereas	unc10112793a	was	reported	to	be	a	plk	inhibitor	dose-response	experiments	supported	the	efficacy	of	these	compounds	to	inhibitgrowth	and	increase	apoptosis	in	2d	cultures	of	these	cells		however		onlyunc10112721a	significantly	inhibited	the	growth	of	3d	spheroids	composed	of	miarcells	and	gfp-tagged	cancer-associated	fibroblasts		multiplexed	inhibitor	bead(mib)-mass	spectrometry	(ms)	kinome	competition	experiments	identified	cdk9	clk1-4		dyrk1a		and	csnk1	as	major	kinase	targets	for	unc10112721a	in	miar	cells	another	cdk9	inhibitor	(cdk-in-2)	replicated	the	growth	inhibitory	effects	ofunc10112721a		whereas	inhibitors	against	the	clk		dyrk		or	csnk1	kinases	had	noeffect		in	summary		these	studies	describe	a	coordinated	approach	to	discovernovel	kinase	inhibitors		evaluate	their	efficacy	in	3d	models		and	define	theirspecificity	against	the	kinome	
